Complete protection against lethal challenge of novel H7N9 virus with heterologous inactivated H7 vaccine in mice

Vaccine

Volumn 32, Issue 42, 2014, Pages 5375-5378

  Tang, Lay Hoon ^a   Lim, Jie Hui ^a   Kuah, Li Fang ^a   Lau, Yuk Fai ^a,b  

^a DSO NATIONAL LABORATORIES   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

H7N9; Influenza; Vaccine

Indexed keywords

AVIAN INFLUENZA VACCINE; INACTIVATED VACCINE; INFLUENZA VACCINE; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVIAN INFLUENZA; CONTROLLED STUDY; INFECTION PREVENTION; INFLUENZA VIRUS A H7N9; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIRUS NEUTRALIZATION; WEIGHT REDUCTION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CROSS REACTION; GENETIC REASSORTMENT; IMMUNOLOGY; INFLUENZA VIRUS A H7N7; ORTHOMYXOVIRIDAE INFECTIONS; SERODIAGNOSIS;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CROSS REACTIONS; INFLUENZA A VIRUS, H7N7 SUBTYPE; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA VACCINES; MICE, INBRED BALB C; NEUTRALIZATION TESTS; ORTHOMYXOVIRIDAE INFECTIONS; REASSORTANT VIRUSES; VACCINES, INACTIVATED;

EID: 84922274844     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.07.087     Document Type: Article

References (16)

1. Belser J.A., Bridges C.B., Katz J.M., Tumpey T.M. Past, present, and possible future human infection with influenza virus A subtype H7. Emerg Infect Dis 2009, 15:859-865.
2. Fouchier R.A.M., Schneeberger P.M., Rozendaal F.W., Broekman J.M., Kemink S.A.G., Munster V., et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A 2004, 101:1356-1361.
3. Min J.-Y., Vogel L., Matsuoka Y., Lu B., Swayne D., Jin H., et al. A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys. J Virol 2010, 84:11950-11960.
4. Joseph T., McAuliffe J., Lu B., Jin H., Kemble G., Subbarao K. Evaluation of replication and pathogenicity of avian influenza a H7 subtype viruses in a mouse model. J Virol 2007, 81:10558-10566.
5. Joseph T., McAuliffe J., Lu B., Vogel L., Swayne D., Jin H., et al. A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets. Virology 2008, 378:123-132.
6. Talaat K.R., Karron R.A., Callahan K.A., Luke C.J., DiLorenzo S.C., Chen G.L., et al. A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. Vaccine 2009, 27:3744-3753.
7. de Wit E., Munster V.J., Spronken M.I.J., Bestebroer T.M., Baas C., Beyer W.E.P., et al. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain. J Virol 2005, 79:12401-12407.
8. Couch R.B., Patel S.M., Wade-Bowers C.L., Niño D. A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine. PLoS ONE 2012, 7:e49704.
9. Hoffmann E., Neumann G., Kawaoka Y., Hobom G., Webster R. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A 2000, 97:6108-6113.
10. Lau Y.F., Tang L.-H., McCall A.W., Ooi E.-E., Subbarao K. An adjuvant for the induction of potent, protective humoral responses to an H5N1 influenza virus vaccine with antigen-sparing effect in mice. J Virol 2010, 84:8639-8649.
11. Watanabe T., Kiso M., Fukuyama S., Nakajima N., Imai M., Yamada S., et al. Characterization of H7N9 influenza A viruses isolated from humans. Nature 2013, 1-7.
12. Xu Q., Chen Z., Cheng X., Xu L., Jin H. Evaluation of live attenuated H7N3 and H7N7 vaccine viruses for their receptor binding preferences, immunogenicity in ferrets and cross reactivity to the novel H7N9 virus. PLOS ONE 2013, 8:e76884.
13. Zhou B., Zhong N., Guan Y. Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med 2007, 357:1450-1451.
14. Hung I.F., To K.K., Lee C.-K., Lee K.-L., Chan K., Yan W.-W., et al. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis 2011, 52:447-456.
15. Khurana S., Verma N., Yewdell J.W., Hilbert A.K., Castellino F., Lattanzi M., et al. MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines. Sci Transl Med 2011, 3:85ra48.
16. Fries L.F., Smith G.E., Glenn G.M. A recombinant virus like particle influenza A (H7N9) vaccine. N Engl J Med 2013, 369:2564-2566.